Abstract LB-A10: Preliminary Results From a Phase 2 Proof of Concept Trial of Tipifarnib in Tumors With HRAS Mutations
doi 10.1158/1535-7163.targ-17-lb-a10
Full Text
Open PDFAbstract
Available in full text
Date
January 1, 2018
Authors
Publisher
American Association for Cancer Research